UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
43.62
-1.88 (-4.13%)
At close: Aug 28, 2026, 4:00 PM EDT
44.98
+1.36 (3.12%)
After-hours: Aug 28, 2026, 7:59 PM EDT

UroGen Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
79.13110.75171.999555.4144.36
Short-Term Investments
28.849.7164.741.9744.5644.78
Cash & Short-Term Investments
107.98120.46236.69136.9799.9689.14
Cash Growth
-31.21%-49.11%72.80%37.02%12.14%-12.62%
Receivables
88.7633.0820.315.4412.711.72
Inventory
24.5916.469.235.674.334.83
Prepaid Expenses
12.7814.678.8510.2811.17.48
Restricted Cash
1.331.351.080.820.811.23
Total Current Assets
235.43186.02276.14169.19128.91114.39
Property, Plant & Equipment
8.239.093.792.363.753.15
Long-Term Investments
--5.024.5-0.68
Other Long-Term Assets
8.945.340.772.262.961.53
Total Assets
252.59200.46285.71178.31135.62119.75

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
15.4712.1410.936.515.535.79
Accrued Expenses
36.7329.127.0720.8415.1113.26
Current Portion of Leases
2.11.761.530.820.941.09
Other Current Liabilities
7.623.436.423.042.342.24
Total Current Liabilities
61.9246.4245.9531.2123.9222.38
Long-Term Debt
188.73122.21121.7398.5597.54-
Long-Term Leases
5.36.121.650.841.590.4
Other Long-Term Liabilities
129.04131.18125.18112.92101.9488.56
Total Liabilities
384.99305.93294.51243.52224.98111.33

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.140.130.120.090.060.06
Additional Paid-In Capital
865.11854.09797.25614.04487.79475.7
Retained Earnings
-997.64-959.72-806.22-679.35-577.1-467.32
Comprehensive Income & Other
-00.020.060.01-0.11-0.03
Total Common Equity
-132.4-105.47-8.8-65.21-89.368.41
Shareholders' Equity
-132.4-105.47-8.8-65.21-89.368.41
Total Liabilities & Equity
252.59200.46285.71178.31135.62119.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
196.13130.09124.92100.21100.061.49
Net Cash (Debt)
-88.15-9.63116.7941.26-0.188.33
Net Cash Growth
--183.09%---12.73%
Net Cash Per Share
-1.78-0.202.721.43-0.003.95
Filing Date Shares Outstanding
48.8848.6846.0934.1223.4422.67
Total Common Shares Outstanding
48.8748.3542.2332.4923.1322.46
Working Capital
173.51139.61230.19137.97104.9992.01
Book Value Per Share
-2.71-2.18-0.21-2.01-3.860.37
Tangible Book Value
-132.4-105.47-8.8-65.21-89.368.41
Tangible Book Value Per Share
-2.71-2.18-0.21-2.01-3.860.37
Machinery
4.714.64.314.023.833.58
Leasehold Improvements
0.630.630.630.620.620.62
SEC Filings: 10-K · 10-Q